Tag: Nasdaq:SWTX
SpringWorks Therapeutics Announces Initiation of Phase 1/2 Clinical Trial of Mirdametinib...
STAMFORD, Conn., June 16, 2021 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing...
SpringWorks Therapeutics to Present at the Cowen 2nd Annual Oncology Innovation...
STAMFORD, Conn., May 14, 2021 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing...
SpringWorks Therapeutics Appoints Bhavesh Ashar as Chief Commercial Officer
STAMFORD, Conn., March 22, 2021 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing...